Signaturefd LLC Sells 161 Shares of STERIS plc (NYSE:STE)

Signaturefd LLC decreased its position in shares of STERIS plc (NYSE:STE) by 4.5% in the 4th quarter, HoldingsChannel reports. The fund owned 3,448 shares of the medical equipment provider’s stock after selling 161 shares during the period. Signaturefd LLC’s holdings in STERIS were worth $758,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Millburn Ridgefield Corp purchased a new position in shares of STERIS during the third quarter valued at approximately $25,000. Catalyst Capital Advisors LLC purchased a new position in shares of STERIS during the third quarter valued at approximately $25,000. Global Wealth Management Investment Advisory Inc. purchased a new position in shares of STERIS during the third quarter valued at approximately $49,000. NBC Securities Inc. purchased a new position in shares of STERIS during the third quarter valued at approximately $50,000. Finally, Exchange Traded Concepts LLC purchased a new position in shares of STERIS during the third quarter valued at approximately $54,000. Hedge funds and other institutional investors own 94.69% of the company’s stock.

STERIS Stock Up 2.5 %

Shares of NYSE STE opened at $205.95 on Wednesday. STERIS plc has a one year low of $180.54 and a one year high of $254.00. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.43 and a quick ratio of 1.49. The business’s fifty day moving average price is $222.85 and its 200-day moving average price is $217.16. The stock has a market capitalization of $20.35 billion, a PE ratio of 36.07 and a beta of 0.79.

STERIS (NYSE:STE) last released its quarterly earnings data on Wednesday, February 7th. The medical equipment provider reported $2.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.17 by $0.05. STERIS had a return on equity of 13.67% and a net margin of 10.48%. The company had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same period in the previous year, the company posted $2.02 EPS. The firm’s revenue for the quarter was up 14.8% compared to the same quarter last year. On average, equities research analysts anticipate that STERIS plc will post 8.67 EPS for the current year.

STERIS Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 22nd. Investors of record on Friday, February 23rd were paid a dividend of $0.52 per share. The ex-dividend date was Thursday, February 22nd. This represents a $2.08 dividend on an annualized basis and a dividend yield of 1.01%. STERIS’s payout ratio is 36.43%.

Wall Street Analyst Weigh In

STE has been the topic of several research analyst reports. JMP Securities reissued a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a research report on Thursday, February 8th. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a research report on Friday, April 12th. KeyCorp initiated coverage on STERIS in a research report on Tuesday, February 6th. They issued an “overweight” rating and a $253.00 price objective on the stock. TheStreet raised STERIS from a “c+” rating to a “b” rating in a research report on Wednesday, February 7th. Finally, Stephens reaffirmed an “overweight” rating and set a $250.00 price target on shares of STERIS in a research report on Friday, February 9th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, STERIS presently has a consensus rating of “Moderate Buy” and a consensus target price of $239.60.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.